Company:  LIGAND PHARMACEUTICALS IN ... (LGND)
Form Type:  S-3ASR
Filing Date:  9/30/2022 
CIK:  0000886163 
Address:  3911 SORRENTO VALLEY BLVD
SUITE 110
 
City, State, Zip:  SAN DIEGO, California 92121 
Telephone:  858-550-7500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$67.86  
Change: 
-1.84 (-2.64%)  
Trade Time: 
12:09 PM EST  
Market Cap: 
$1.15B
Trade LGND now with 

© 2022  
Description of Business
We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We employ research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. We currently have partnerships and license agreements with over 140 pharmaceutical and biotechnology companies. Over 400 programs are in various stages of commercialization, development or research and are fully funded by our collaboration partners and licensees. We have contributed novel research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and postpartum depression, among others.
Register and access this filing in:     
  FORM S-3ASR
    EXPLANATORY NOTE
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS
    WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
    RISK FACTORS
    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    DIVIDEND POLICY
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    DESCRIPTION OF DEBT SECURITIES
    No Personal Liability of Directors, Officers, Employees or ...
    DESCRIPTION OF WARRANTS
    DESCRIPTION OF UNITS
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    THE OFFERING
    RISK FACTORS
    USE OF PROCEEDS
    DILUTION
    PART II
      Item 14. Other Expenses of Issuance and Distribution
      Item 15. Indemnification of Directors and Officers
      Item 16. Exhibits
      Item 17. Undertakings
    SIGNATURES
    POWER OF ATTORNEY
  EXHIBIT 1.2
  EXHIBIT 4.3
  EXHIBIT 5.1
  EXHIBIT 5.2
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm
  EXHIBIT FILING FEES